Deep Insights from the Experts
Growth Advisory
Technology | IP Research & Intelligence
Investment Research & Analytics
Valuation & Financial Advisory
Valuing a company for acquisition is one of the most critical steps in the mergers and acquisitions process. A well-structured valuation not only determines the price a buyer is willing to pay but also shapes ...read more
published on May 25, 2026
India currently relies on imports to meet its carbon fiber needs, even as the demand continues to expand across wind energy, aerospace manufacturing, and electric mobility. Most of the carbon fiber consumed domestically is sourced ...read more
published on May 21, 2026
ESG reporting in 2026 are transforming how organizations disclose sustainability performance, climate risk exposure and governance practices. Regulatory bodies across the European Union, the United States and global financial markets are moving from voluntary sustainability disclosures ...read more
published on May 19, 2026
Climate change is no longer a peripheral environmental concern. It is now recognized as a core financial and strategic risk factor influencing capital allocation, regulatory oversight and investor expectations. Organizations across sectors are now required ...read more
published on May 15, 2026
Type 1 diabetes, once considered a lifelong affliction requiring constant management, has seen remarkable advancements in recent years, particularly in the field of alternative therapies. The traditional management of type 1 diabetes involves daily insulin injections or ...read more
published on Jul 10, 2024
Net zero energy buildings (NZEBs) are transforming the landscape of sustainable construction through global regulatory support, major technological advancements, and innovative design practices. The surge in patent filings reflects intensified research and development efforts by ...read more
published on Jun 27, 2024
Type 1 diabetes results from intricate interactions between genetic predisposition and environmental triggers. Existing treatments often fall short of providing sustained relief, prompting the search for alternative solutions. Gene therapy offers such avenues by either reprogramming ...read more
published on Apr 19, 2024
Type 1 diabetes (T1D) is a complex autoimmune disease with a multifactorial etiology. Genetic predisposition, environmental triggers, and immune dysregulation contribute to the development of this chronic condition. Diagnoses involves a combination of clinical evaluation, ...read more
published on Apr 12, 2024
Immersive technology encompassing AR, VR, and MR is revolutionizing how we interact with digital content, enabling lifelike, engaging experiences across healthcare, education, retail, and defense. Companies are leveraging it to boost productivity, cut costs, and ...read more
published on Jul 31, 2025
“Investing with Faith: The Rise and Reach of Halal Investments” explores how faith-driven finance is transforming global markets. It outlines the principles of Halal investing, rooted in Shariah law—prohibiting interest, gambling, and ...read more
published on Jun 25, 2025
Despite multiple interventions, Vodafone Idea remains trapped in a cycle of high debt, regulatory overhang, and underinvestment. With dwindling subscriber share and a growing capex gap versus rivals Jio and Airtel, Vi’s future as a ...read more
published on Jun 23, 2025
As the U.S. considers imposing a 25% tariff on iPhones manufactured abroad, Apple is under pressure to shift production from India to the U.S. However, such a transition is economically unviable. Producing an iPhone ...read more
published on Jun 13, 2025
A Veterinary Partner in the USA acquired 41 veterinary clinics and 3 pet boarding facilities in a single transaction, Aranca navigated complex valuation issues with expertise. They accurately identified and valued intangibles, and goodwill for each location. ...read more
published on Aug 28, 2024
Financial Accounting Standard (FAS) 141 was first implemented in 2001. It is now codified as ASC 805, Business Combinations. Business combinations mean the acquisition of one company by another. They play a significant role in shaping the corporate ...read more
published on Aug 12, 2024
In 2024, the biopharmaceutical industry has witnessed an unprecedented surge in the number of unicorns, i.e., privately held startups valued at over $1 billion. These unicorns are taking the lead, getting ready to go public and ...read more
published on Jul 05, 2024
Valuation of companies for financial reporting has always been vexing. Valuation methodologies adopted for investment analysis can drastically vary from those deployed for reporting the investments at fair value for financial reporting (ASC 820). While the ...read more
published on May 27, 2024
© , Aranca. All rights reserved.
